CANCELLED – ICTS/Venture Café Seminar: Brian Kim (WashU Medicine), Duke Leahy ( – “Finding Relief for Chronic Itch: From drug discovery to a Center for Excellence”

July 16, 2020
4:00 pm - 5:00 pm
Zoom conference

“Finding Relief for Chronic Itch: From drug discovery to a Center for Excellence”

Discovery of a New Drug to a Digital Center of Excellence for Chronic Itch: Based on the original discovery in the Kim Lab at WashU that Janus kinase (JAK) signaling in neurons critically mediates itch, Dr. Brian Kim and Duke Leahey co-founded Nuogen Pharma to develop JAK inhibitors for itch by way of a novel route of delivery. Currently, there are no FDA-approved medications specifically for chronic itch. Beyond treatments, recognizing the highly unmet need for patients in terms of diagnosis, education, management, and access, Dr. Kim and Duke decided to start an online digital center of excellence called SootheRx. This platform aims to revolutionize and innovate the delivery of care itself while simultaneously bringing new treatments to patients with chronic itch in the most effective and efficient manner possible.

For inquiries contact Trisha Salyer.

The Institute of Clinical and Translational Sciences (ICTS) Precision Medicine team invites you to an on-going collaboration with Venture Café.  On the third Thursday of every month , ICTS Precision Medicine hosts a session featuring WashU faculty working in translational genomics/precision medicine areas. Talks are typically oriented toward biotechnology, diagnostics, informatics, start-ups and precision interventions based on medical genomics innovations.

For more information visit the ICTS Precision Medicine website.